Further work is needed to elucidate the role of viral and bacterial infections in the disease progression in patients with GOSR2 deficiency and how pathogen-induced perturbation of vesicular trafficking may eventually trigger neurodegeneration. This evidence concerns the gene GOSR2 and bacterial infectious disease.